Monday, October 20, 2014 12:52:57 PM
Many who scalp this idea may also have a rule, such as at least 5% or greater to scalp. Then a 'proven wrong' stop loss order.
For our CTIX, so far our tiny opening gaps have tended to fill. True in hindsight. But we could also see CTIX runaway gaps that never fill. Or only do so after big moves. Especially on news, rumour, or just a big player entering the arena.
There's almost no simplistic TA based system that makes money. Otherwise it would be widely used and the edge would disappear. That's why there are so many TA systems and courses for sale. They don't work. Those who can't do, tech.
The best TA folks have several years of experience, complex systems with multiple time frames, at least 2 or 3 indicators, complex entry and exit rules, and historical back-tests with thousands of data points. Most of them don't make money, lol. And even those with a winning system tend to lose over-all or under-perform their systems because of all the psychological traps and challenges of trading; impulsiveness, off-plan trades, melt-down days, etc.
The best TA people appear to use a combination of TA, feel, guidelines for scaling in and out, and mixed with a knowledge of fundamentals. That is playing stocks they understand and have reason to be bullish about. They are few. We are many.
"Games are won by players who focus on the playing field -- not by those whose eyes are glued to the scoreboard." - Warren Buffett
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM